![Kamalam Unninayar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kamalam Unninayar served as the Chief Financial Officer at Harvard Bioscience, Inc. from 2018 to 2019 and at Tetraphase Pharmaceuticals, Inc. from 2017 to 2018.
She received a graduate degree from Wichita State University and both undergraduate and graduate degrees from the University of Delhi.
Eerdere bekende functies van Kamalam Unninayar
| Bedrijven | Functie | Einde |
|---|---|---|
| HARVARD BIOSCIENCE, INC. | Financieel Directeur/CFO | 31-05-2019 |
| TETRAPHASE PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 16-03-2018 |
Opleiding van Kamalam Unninayar
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Wichita State University
 Wichita State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
